Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1

Anesthesiology

Volumn 118, Issue 5, 2013, Pages 1140-1149

  Cai, Meiting ^a   Chen, Qixing ^a   Chen, Chi ^a   Liu, Xiwang ^a   Hou, Jinchao ^a   Zeng, Congli ^a   Shu, Qiang ^a   Fang, Xiangming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STAUROSPORINE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOCYTE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; APACHE; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; DEPENDOVIRUS; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; LENGTH OF STAY; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; MULTIPLE ORGAN FAILURE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; SEPSIS; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL;

EID: 84877586039     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828744a5     Document Type: Article

References (34)

1. Shi C, Pamer EG: Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74
2. Soehnlein O, Lindbom L: Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10:427-39
3. Parihar A, Eubank TD, Doseff AI: Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun 2010; 2:204-15
4. Fuchs Y, Steller H: Programmed cell death in animal development and disease. Cell 2011; 147:742-58
5. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE: Cell death. N Engl J Med 2009; 361:1570-83
6. Muñoz-Pinedo C: Signaling pathways that regulate life and cell death: Evolution of apoptosis in the context of selfdefense. Adv Exp Med Biol 2012; 738:124-43
7. Colonna M: TREMs in the immune system and beyond. Nat Rev Immunol 2003; 3:445-53
8. Bouchon A, Dietrich J, Colonna M: Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164:4991-5
9. Netea MG, Azam T, Ferwerda G, Girardin SE, Kim SH, Dinarello CA: Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol 2006; 80:1454-61
10. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410:1103-7
11. Ford JW, McVicar DW: TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009; 21:38-46
12. Bosco MC, Pierobon D, Blengio F, Raggi F, Vanni C, Gattorno M, Eva A, Novelli F, Cappello P, Giovarelli M, Varesio L: Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: Identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 2011; 117:2625-39
13. Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Béné MC, Faure GC, Lévy B: Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med 2005; 31:594-7
14. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T: Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 2004; 173:7131-4
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6
16. Cappon A, Babolin C, Segat D, Cancian L, Amedei A, Calzetti F, Cassatella MA, D'Elios MM, de Bernard M: Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. Cell Microbiol 2010; 12:754-64
17. Wu S, Zhang K, Lv C, Wang H, Cheng B, Jin Y, Chen Q, Lian Q, Fang X: Nuclear factor-κB mediated lipopolysaccharideinduced mRNA expression of hepcidin in human peripheral blood leukocytes. Innate Immun 2012; 18:318-24
18. Shu Q, Shi Z, Zhao Z, Chen Z, Yao H, Chen Q, Hoeft A, Stuber F, Fang X: Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats. Shock 2006; 26:365-71
19. Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, Yasui H, Shiraishi N, Chauhan D, Munshi NC, Green SR, Anderson KC: Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclindependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma. Blood 2005; 106:1042-7
20. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, Gray M, Crescenzi E, Martin MC, Brady HJ, Savill JS, Dransfield I, Haslett C: Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006; 12:1056-64
21. Leitch AE, Riley NA, Sheldrake TA, Festa M, Fox S, Duffin R, Haslett C, Rossi AG: The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override proinflammatory signalling and drive neutrophil apoptosis. Eur J Immunol 2010; 40:1127-38
22. Tessarz AS, Cerwenka A: The TREM-1/DAP12 pathway. Immunol Lett 2008; 116:111-6
23. Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL: Innate immune responses to TREM-1 activation: Overlap, divergencE, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 2008; 180:3520-34
24. Giamarellos-Bourboulis EJ, Routsi C, Plachouras D, Markaki V, Raftogiannis M, Zervakis D, Koussoulas V, Orfanos S, Kotanidou A, Armaganidis A, Roussos C, Giamarellou H: Early apoptosis of blood monocytes in the septic host: Is it a mechanism of protection in the event of septic shock Crit Care 2006; 10:R76
25. Yu Q, Chow EM, Wong H, Gu J, Mandelboim O, Gray-Owen SD, Ostrowski MA: CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinaseand AKT-dependent pathway. J Biol Chem 2006; 281: 39179-93
26. Numata T, Araya J, Fujii S, Hara H, Takasaka N, Kojima J, Minagawa S, Yumino Y, Kawaishi M, Hirano J, Odaka M, Morikawa T, Nishimura SL, Nakayama K, Kuwano K: Insulindependent phosphatidylinositol 3-kinase/Akt and ERK signaling pathways inhibit TLR3-mediated human bronchial epithelial cell apoptosis. J Immunol 2011; 187:510-9
27. Prieto P, Cuenca J, Través PG, Fernández-Velasco M, Martín-Sanz P, Boscá L: Lipoxin A4 impairment of apoptotic signaling in macrophages: Implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ 2010; 17:1179-88
28. Dai Y, Rahmani M, Pei XY, Khanna P, Han SI, Mitchell C, Dent P, Grant S: Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK. Blood 2005; 105:1706-16
29. Youle RJ, Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9:47-59
30. Warr MR, Shore GC: Unique biology of Mcl-1: Therapeutic opportunities in cancer. Curr Mol Med 2008; 8:138-47
31. Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 2009; 66:1326-36
32. Chan G, Nogalski MT, Bentz GL, Smith MS, Parmater A, Yurochko AD: PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J Immunol 2010; 184:3213-22
33. Ding Q, Huo L, Yang JY, Xia W, Wei Y, Liao Y, Chang CJ, Yang Y, Lai CC, Lee DF, Yen CJ, Chen YJ, Hsu JM, Kuo HP, Lin CY, Tsai FJ, Li LY, Tsai CH, Hung MC: Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 2008; 68:6109-17
34. Sun HL, Tsai AC, Pan SL, Ding Q, Yamaguchi H, Lin CN, Hung MC, Teng CM: EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation. Clin Cancer Res 2009; 15:4904-14